Skip to main content
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.460
-0.060 (-2.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Acumen Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
177.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Protalix BioTherapeutics 52.74M
Precision BioSciences 34.26M
Tonix Pharmaceuticals Holding 13.11M
Korro Bio 6.39M
Cartesian Therapeutics 2.80M
Humacyte 2.04M
Revenue Rankings

ABOS News

More News